The Efficacy and Sustainability of an Implementation Intervention (FOCUS Program) on Linkage to Hepatitis C Care Time at a Community Health Center in the Deep South: A Longitudinal Study Based on Electronic Medical Records [0.03%]
基于电子病历的纵向研究：社区卫生中心深南地区肝炎C保健联系时间的执行干预（FOCUS项目）的有效性和可持续性
Adelero Adebajo,Shan Qiao,Irene Esu et al.
Adelero Adebajo et al.
People with hepatitis C should be identified and promptly linked to care after diagnosis to eliminate hepatitis C virus (HCV) infection by 2030. An implementation intervention, an HCV screening and linkage to care intervention, the FOCUS pr...
Impact of Universal Screening for HDV in HBV-Infected Patients on Chronic HDV Detection Rate in Israel [0.03%]
以色列HBV感染患者进行普遍筛查对慢性HDV检测率的影响
David Yardeni,Omer Cividalli,Bryan Itkowitz et al.
David Yardeni et al.
Hepatitis delta virus (HDV) and hepatitis B virus (HBV) co-infection is considered a progressive chronic viral hepatitis where treatment options are limited and significant morbidity and mortality are prevalent. Studies have shown insuffici...
Prospective Evaluation of Blood Borne Virus Testing in Custody Suites in North-East England [0.03%]
英格兰东北部看守室血源性病毒检测的前瞻性评价
Danielle Rayner,Francesca McCullough,Kate McQue et al.
Danielle Rayner et al.
Drug-related crime is a common reason for arrest. Therefore, some arrested individuals are at risk of hepatitis C virus infection (HCV). We present the outcomes of a blood borne virus (BBV) testing programme in custody suites in North-East ...
Scoping Review on Strategies for Safe Nucleot(s)ide Analogue Discontinuation and Optimising Functional Cure in Chronic Hepatitis B [0.03%]
慢性乙型肝炎安全停用核苷（酸）类似物策略和功能性治愈的优化方案综合回顾性研究
Soe Thiha Maung,Roongruedee Chaiteerakij
Soe Thiha Maung
Chronic hepatitis B (CHB) remains a global health challenge, contributing to significant morbidity and mortality. While long-term nucleos(t)ide analogue (NA) therapy effectively suppresses viral replication, achieving a functional cure rema...
COVID-19 and Liver Injury, Beyond the First Pandemic Waves: Clinical and Immune-Virological Features [0.03%]
新冠大流行第二波疫情中的肝损伤：临床和免疫-病毒学特征
Luca Foroghi Biland,Andrea Di Lorenzo,Francesco De Maria et al.
Luca Foroghi Biland et al.
A liver involvement in Coronavirus disease 19 (COVID-19) has been frequently observed in patients hospitalised for severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection during 2020; in such cases, the clinical and prognosti...
A Person-Centered Hepatitis B Approach Using the COM-B Model to Understand Barriers and Facilitators of Hepatitis B Testing, Management and Treatment [0.03%]
基于COM-B模型的人际导向的乙型肝炎方法，用于理解阻碍和促进乙型肝炎检测、管理和治疗的因素
Catherine Freeland,Quinn Plunkett,Shruti Sirapu et al.
Catherine Freeland et al.
Over 250 million individuals live with chronic hepatitis B worldwide. More work is needed to address care gaps associated with chronic hepatitis B. Behavioural theories can assist in understanding gaps and aid in the development of effectiv...
Unhealthy Behaviours and All-Cause Mortality Among People With Chronic Hepatitis B, With and Without Hepatitis Delta (ANRS CO22 HEPATHER) [0.03%]
慢性乙型肝炎伴或不伴有δ型肝炎患者的不健康行为与全因死亡率的关系(ANRS CO22 HEPATHER研究)
Clémence Ramier,Fabrice Carrat,Vincent Di Beo et al.
Clémence Ramier et al.
People infected with both hepatitis B virus (HBV) and hepatitis Delta virus (HDV) face a higher mortality risk than those mono-infected with HBV. As unhealthy behaviours can influence liver disease progression, we compared the effects of va...
Leading Role of Sofosbuvir/Daclatasvir in Achieving Hepatitis C Elimination in Egypt [0.03%]
索磷布韦/达卡他韦治疗在埃及实现丙肝根除中的主导作用
Tamer Elbaz,Khalid Al-Naamani,Hazem Abosheaishaa et al.
Tamer Elbaz et al.
Chronic hepatitis C virus (HCV) management has historically been challenging, particularly in Egypt, the country with the highest global disease prevalence. The introduction of direct-acting antivirals (DAAs) has revolutionised treatment, p...
Increasing Treatment Uptake for Chronic Hepatitis B in South America: A Comparative Analysis of Country-Specific and WHO 2024 Guidelines [0.03%]
南美洲慢性乙肝治疗率的提升：国家特定指南与世卫组织2024年指南比较分析
Manuel Mendizabal,Constanza D Sabate,Esteban González Ballerga et al.
Manuel Mendizabal et al.
The 2024 WHO guidelines for chronic hepatitis B (CHB) aim to expand and simplify treatment eligibility. We aimed to estimate treatment eligibility and uptake according to country-specific guidelines and evaluate treatment expansion based on...
Comparative Study
Journal of viral hepatitis. 2025 Jun;32(6):e70035. DOI:10.1111/jvh.70035 2025
Universal HCV Screening in Hospitalised Patients in France: It Could Be a Good Option! The DEVICHO Study [0.03%]
法国住院患者的普遍丙肝筛查：或许是一个好选择！DEVICHO研究
Si Ahmed Si Nafa,Souad Benali,Guillaume Penaranda et al.
Si Ahmed Si Nafa et al.
In France, chronic hepatitis C whatever fibrosis stage or comorbidities can be freely treated by any physician. However, screening is still currently based on risk factors, and universal screening remains controversial. The aims of this pro...